<!DOCTYPE html>

<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>WAAMS - Western Australia AntiMicrobial Stewardship</title>
    <link rel="shortcut icon" type="image/ico" href="favicon.ico" />
    <link rel="apple-touch-icon" href="apple-touch-icon-precomposed.png">
    <link rel="apple-touch-icon-precomposed" href="apple-touch-icon-precomposed.png">
    <link rel="stylesheet" href="bootstrap/css/bootstrap.min.css" />
    <link rel="stylesheet" href="bootstrap/css/bootstrap-theme.min.css" />
    <link rel="stylesheet" href="bootstrap/css/basic.css" />
    <link rel="stylesheet" href="bootstrap/css/style.css" />
    <script src="bootstrap/js/jquery-1.11.1.min.js"></script>
    <script type="text/javascript" src="bootstrap/js/codecheckWA.js"></script>
    <!-- Needed for Forms Feature Detection -->
    <script src="polyfill/better-dom.min.js"></script>
    <!-- Needed for Validation -->
    <script src="polyfill/better-dateinput-polyfill.js"></script>
    <script src="polyfill/ie-array-polyfill.js"></script>
    <!-- General helpful functions -->
    <script src="bootstrap/js/kraken.js"></script>
</head>

<body>

    <!-- loading page -->
    <div data-role="page" id="load" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Loading</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Loading</span>
            </h3>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /load -->

    <!-- start of ACUTE BACTERIAL PROSTATITIS treatment maze -->

    <!-- Start of Acute bacterial prostatitis page ?PEN -->
    <div data-role="page" id="prostati" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acute Bacterial Prostatitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">See below for details on penicillin allergy severity</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#prostati1b">No penicillin allergy</a></li>
                <li><a href="#prostati2b">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#prostati3b">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patientâ€™s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /prostati -->

    <!-- Start of BACTERIAL PROSTATITIS page NO PEN ?Severe-->
    <div data-role="page" id="prostati1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acute Bacterial Prostatitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the infection severe or non-severe?</span>
            </h3>
            <hr />
            <ul class="line30">
                <li>Acute bacterial prostatitis is considered severe if the patient has fever (38Â°C or higher), systemic features (eg chills, sweats), or sepsis or septic shock</li>
                <li>If the patient is septic, please also see <a href="sepsisNsimilar.html#sepsis">treatment for sepsis</a> for further advice</li>
            </ul>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#prostati1b1">Severe and/or septic</a></li>
                <li><a href="#prostati1b2">Non-severe</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /prostati1b -->

    <!-- Start of BACTERIAL PROSTATITIS page MILD PEN ?Severe-->
    <div data-role="page" id="prostati2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acute Bacterial Prostatitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the infection severe or non-severe?</span>
            </h3>
            <hr />
            <ul class="line30">
                <li>Acute bacterial prostatitis is considered severe if the patient has fever (38Â°C or higher), systemic features (eg chills, sweats), or sepsis or septic shock</li>
                <li>If the patient is septic, please also see <a href="sepsisNsimilar.html#sepsis">treatment for sepsis</a> for further advice</li>
            </ul>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#prostati2b1">Severe and/or septic</a></li>
                <li><a href="#prostati2b2">Non-severe</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /prostati2b -->

    <!-- Start of BACTERIAL PROSTATITIS page BAD PEN ?Severe -->
    <div data-role="page" id="prostati3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acute Bacterial Prostatitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the infection severe or non-severe?</span>
            </h3>
            <hr />
            <ul class="line30">
                <li>Acute bacterial prostatitis is considered severe if the patient has fever (38Â°C or higher), systemic features (eg chills, sweats), or sepsis or septic shock</li>
                <li>If the patient is septic, please also see <a href="sepsisNsimilar.html#sepsis">treatment for sepsis</a> for further advice</li>
            </ul>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#prostati3b1">Severe and/or septic</a></li>
                <li><a href="#prostati3b2">Non-severe</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /prostati3b -->

    <!-- Start of BACTERIAL PROSTATITIS page BAD PEN, Severe, ?Gent -->
    <div data-role="page" id="prostati3b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acute Bacterial Prostatitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#prostati2b1a">Gentamicin not contraindicated</a></li>
                <li><a href="#prostatix">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /prostati3b1 -->

    <!-- Start of BACTERIAL PROSTATITIS page NO PEN, Severe, ?Gent -->
    <div data-role="page" id="prostati1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acute Bacterial Prostatitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#prostati1b1a">Gentamicin not contraindicated</a></li>
                <li><a href="#prostati1b1b">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /prostati1b1 -->

    <!-- Start of BACTERIAL PROSTATITIS page MILD PEN, Severe, ?Gent -->
    <div data-role="page" id="prostati2b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acute Bacterial Prostatitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#prostati2b1a">Gentamicin not contraindicated</a></li>
                <li><a href="#prostati1b1b">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /prostati2b1 -->

    <!-- Start of BACTERIAL PROSTATITIS page BAD PEN, Severe, ?Gent -->
    <div data-role="page" id="prostati3b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acute Bacterial Prostatitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#prostati2b1a">Gentamicin not contraindicated</a></li>
                <li><a href="#prostatix">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /prostati3b1 -->


    <!-- Start of BACTERIAL PROSTATITIS page NO PEN, Severe, Gent OK -->
    <div data-role="page" id="prostati1b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acute Bacterial Prostatitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient does not have a penicillin allergy and does not have a
                    contraindication to aminoglycosides give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 2 g IV, 6-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>abp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>The total duration of therapy (intravenous + oral) is usually 4 weeks.</li>
                <li>Acute bacterial prostatitis is caused by similar organisms to those associated with other UTIs (eg <i>Escherichia coli</i>, <i>Proteus</i> species, <i>Klebsiella</i> species). However, sexually transmitted pathogens (ie <i>Chlamydia trachomatis</i>, <i>Neisseria gonorrhoeae</i>) may also cause acute bacterial prostatitis. Systemic pathogens (eg <i>Burkholderia pseudomallei</i>; see Melioidosis) rarely cause infection, except in tropical regions of Australia</li>
                <li>Acute bacterial prostatitis usually presents with symptoms associated with urinary tract infection (UTI) (eg acute dysuria, urinary frequency and urgency), and systemic features (eg fever [38Â°C or higher], chills, sweats). Obstructive urinary symptoms (eg weak stream, dribbling, hesitancy or urinary retention) and symptoms suggestive of prostatic involvement (eg pelvic or perineal pressure, or prostate tenderness on gentle digital rectal examination) may also be present.</li>
                <li>Acute bacterial prostatitis following genitourinary instrumentation (eg transrectal ultrasound-guided prostate biopsy) is often associated with sepsis and multidrug-resistant Gram-negative bacteriaâ€”seek expert advice</li>
                <li>Obtain urine samples for culture and susceptibility testing for patients with acute bacterial prostatitis. For patients in hospital, also collect blood samples for culture and susceptibility testing</li>
                <li>Prostatic abscess can complicate prostatitis. Imaging (eg transrectal ultrasound, CT scan, MRI) can identify prostatic abscesses that may require drainage</li>
                <li>Confirm the infection has resolved by repeating urine culture 1 week after treatment is completed</li>
                <li>Modify empirical therapy based on the results of culture and susceptibility testing. Do not continue empiric gentamicin for more than 48 hours</li>
                <li>See the <a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on epididymo-orchitis or acute bacterial prostatitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /prostati1b1a -->

    <!-- Start of BACTERIAL PROSTATITIS page NO PEN, Severe, Gent BAD -->
    <div data-role="page" id="prostati1b1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acute Bacterial Prostatitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a contraindication to aminoglycosides give as a single agent:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 1 g intravenously, daily</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>abp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>The total duration of therapy (intravenous + oral) is usually 4 weeks.</li>
                <li>Acute bacterial prostatitis is caused by similar organisms to those associated with other UTIs (eg <i>Escherichia coli</i>, <i>Proteus</i> species, <i>Klebsiella</i> species). However, sexually transmitted pathogens (ie <i>Chlamydia trachomatis</i>, <i>Neisseria gonorrhoeae</i>) may also cause acute bacterial prostatitis. Systemic pathogens (eg <i>Burkholderia pseudomallei</i>; see Melioidosis) rarely cause infection, except in tropical regions of Australia</li>
                <li>Acute bacterial prostatitis usually presents with symptoms associated with urinary tract infection (UTI) (eg acute dysuria, urinary frequency and urgency), and systemic features (eg fever [38Â°C or higher], chills, sweats). Obstructive urinary symptoms (eg weak stream, dribbling, hesitancy or urinary retention) and symptoms suggestive of prostatic involvement (eg pelvic or perineal pressure, or prostate tenderness on gentle digital rectal examination) may also be present.</li>
                <li>Acute bacterial prostatitis following genitourinary instrumentation (eg transrectal ultrasound-guided prostate biopsy) is often associated with sepsis and multidrug-resistant Gram-negative bacteriaâ€”seek expert advice</li>
                <li>Obtain urine samples for culture and susceptibility testing for patients with acute bacterial prostatitis. For patients in hospital, also collect blood samples for culture and susceptibility testing</li>
                <li>Prostatic abscess can complicate prostatitis. Imaging (eg transrectal ultrasound, CT scan, MRI) can identify prostatic abscesses that may require drainage</li>
                <li>Confirm the infection has resolved by repeating urine culture 1 week after treatment is completed</li>
                <li>Modify empirical therapy based on the results of culture and susceptibility testing</li>
            </ul>     
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on epididymo-orchitis or acute bacterial prostatitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /prostati1b1b -->

    <!-- Start of BACTERIAL PROSTATITIS page NO PEN, NOT Severe -->
    <div data-role="page" id="prostati1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acute Bacterial Prostatitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has no penicillin allergy and the infection is not severe give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for 2 weeks</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefalexin 500 mg orally, 6-hourly for 2 weeks</span>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>OR,</b> if resistance to all of the above drugs is confirmed and the pathogen is susceptible, a suitable alternative is:</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ciprofloxacin 500 mg orally, 12-hourly for 2 weeks</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Norfloxacin 400 mg orally, 12-hourly for 2 weeks</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ciprofloxacin is:</span>
                <span class="font15 bold"> 14<script> document.write(getCode())</script>abp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOURTEEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is
                    to continue past two weeks. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>The total duration of therapy for non-severe acute bacterial protatitis is usually 2 weeks.</li>
                <li>Acute bacterial prostatitis is caused by similar organisms to those associated with other UTIs (eg <i>Escherichia coli</i>, <i>Proteus</i> species, <i>Klebsiella</i> species). However, sexually transmitted pathogens (ie <i>Chlamydia trachomatis</i>, <i>Neisseria gonorrhoeae</i>) may also cause acute bacterial prostatitis. Systemic pathogens (eg <i>Burkholderia pseudomallei</i>; see Melioidosis) rarely cause infection, except in tropical regions of Australia</li>
                <li>Acute bacterial prostatitis usually presents with symptoms associated with urinary tract infection (UTI) (eg acute dysuria, urinary frequency and urgency), and systemic features (eg fever [38Â°C or higher], chills, sweats). Obstructive urinary symptoms (eg weak stream, dribbling, hesitancy or urinary retention) and symptoms suggestive of prostatic involvement (eg pelvic or perineal pressure, or prostate tenderness on gentle digital rectal examination) may also be present.</li>
                <li>Acute bacterial prostatitis following genitourinary instrumentation (eg transrectal ultrasound-guided prostate biopsy) is often associated with sepsis and multidrug-resistant Gram-negative bacteriaâ€”seek expert advice</li>
                <li>Obtain urine samples for culture and susceptibility testing for patients with acute bacterial prostatitis. For patients in hospital, also collect blood samples for culture and susceptibility testing</li>
                <li>Prostatic abscess can complicate prostatitis. Imaging (eg transrectal ultrasound, CT scan, MRI) can identify prostatic abscesses that may require drainage</li>
                <li>Confirm the infection has resolved by repeating urine culture 1 week after treatment is completed</li>
                <li>Modify empirical therapy based on the results of culture and susceptibility testing</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on epididymo-orchitis or acute bacterial prostatitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /prostati1b2 -->

    <!-- Start of BACTERIAL PROSTATITIS page MILD PEN, NOT Severe -->
    <div data-role="page" id="prostati2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acute Bacterial Prostatitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has no penicillin allergy or non-severe penicillin allergy and the infection is not severe give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for 2 weeks</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefalexin 500 mg orally, 6-hourly for 2 weeks</span>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>OR,</b> if resistance to all of the above drugs is confirmed and the pathogen is susceptible, a suitable alternative is:</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ciprofloxacin 500 mg orally, 12-hourly for 2 weeks</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Norfloxacin 400 mg orally, 12-hourly for 2 weeks</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ciprofloxacin is:</span>
                <span class="font15 bold"> 14<script> document.write(getCode())</script>abp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOURTEEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is
                    to continue past two weeks. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use trimethoprim instead</li>
                <li>The total duration of therapy for non-severe acute bacterial protatitis is usually 2 weeks.</li>
                <li>Acute bacterial prostatitis is caused by similar organisms to those associated with other UTIs (eg <i>Escherichia coli</i>, <i>Proteus</i> species, <i>Klebsiella</i> species). However, sexually transmitted pathogens (ie <i>Chlamydia trachomatis</i>, <i>Neisseria gonorrhoeae</i>) may also cause acute bacterial prostatitis. Systemic pathogens (eg <i>Burkholderia pseudomallei</i>; see Melioidosis) rarely cause infection, except in tropical regions of Australia</li>
                <li>Acute bacterial prostatitis usually presents with symptoms associated with urinary tract infection (UTI) (eg acute dysuria, urinary frequency and urgency), and systemic features (eg fever [38Â°C or higher], chills, sweats). Obstructive urinary symptoms (eg weak stream, dribbling, hesitancy or urinary retention) and symptoms suggestive of prostatic involvement (eg pelvic or perineal pressure, or prostate tenderness on gentle digital rectal examination) may also be present.</li>
                <li>Acute bacterial prostatitis following genitourinary instrumentation (eg transrectal ultrasound-guided prostate biopsy) is often associated with sepsis and multidrug-resistant Gram-negative bacteriaâ€”seek expert advice</li>
                <li>Obtain urine samples for culture and susceptibility testing for patients with acute bacterial prostatitis. For patients in hospital, also collect blood samples for culture and susceptibility testing</li>
                <li>Prostatic abscess can complicate prostatitis. Imaging (eg transrectal ultrasound, CT scan, MRI) can identify prostatic abscesses that may require drainage</li>
                <li>Confirm the infection has resolved by repeating urine culture 1 week after treatment is completed</li>
                <li>Modify empirical therapy based on the results of culture and susceptibility testing</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on epididymo-orchitis or acute bacterial prostatitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /prostati2b2 -->

    <!-- Start of BACTERIAL PROSTATITIS page BAD PEN, NOT Severe -->
    <div data-role="page" id="prostati3b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acute Bacterial Prostatitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a severe penicillin allergy and the infection is not severe give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for 2 weeks</span>
                </h4>
            </div>
            <br/>
            <div id="backcolour">
                <p class="mrgn20b"><b>OR,</b> if resistance to all of the above drugs is confirmed and the pathogen is susceptible, a suitable alternative is:</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ciprofloxacin 500 mg orally, 12-hourly for 2 weeks</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Norfloxacin 400 mg orally, 12-hourly for 2 weeks</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ciprofloxacin is:</span>
                <span class="font15 bold"> 14<script> document.write(getCode())</script>abp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOURTEEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is
                    to continue past two weeks. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>The total duration of therapy for non-severe acute bacterial protatitis is usually 2 weeks.</li>
                <li>Acute bacterial prostatitis is caused by similar organisms to those associated with other UTIs (eg <i>Escherichia coli</i>, <i>Proteus</i> species, <i>Klebsiella</i> species). However, sexually transmitted pathogens (ie <i>Chlamydia trachomatis</i>, <i>Neisseria gonorrhoeae</i>) may also cause acute bacterial prostatitis. Systemic pathogens (eg <i>Burkholderia pseudomallei</i>; see Melioidosis) rarely cause infection, except in tropical regions of Australia</li>
                <li>Acute bacterial prostatitis usually presents with symptoms associated with urinary tract infection (UTI) (eg acute dysuria, urinary frequency and urgency), and systemic features (eg fever [38Â°C or higher], chills, sweats). Obstructive urinary symptoms (eg weak stream, dribbling, hesitancy or urinary retention) and symptoms suggestive of prostatic involvement (eg pelvic or perineal pressure, or prostate tenderness on gentle digital rectal examination) may also be present.</li>
                <li>Acute bacterial prostatitis following genitourinary instrumentation (eg transrectal ultrasound-guided prostate biopsy) is often associated with sepsis and multidrug-resistant Gram-negative bacteriaâ€”seek expert advice</li>
                <li>Obtain urine samples for culture and susceptibility testing for patients with acute bacterial prostatitis. For patients in hospital, also collect blood samples for culture and susceptibility testing</li>
                <li>Prostatic abscess can complicate prostatitis. Imaging (eg transrectal ultrasound, CT scan, MRI) can identify prostatic abscesses that may require drainage</li>
                <li>Confirm the infection has resolved by repeating urine culture 1 week after treatment is completed</li>
                <li>Modify empirical therapy based on the results of culture and susceptibility testing</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on epididymo-orchitis or acute bacterial prostatitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /prostati3b2 -->

    <!-- Start of BACTERIAL PROSTATITIS page MILD or BAD PEN, Severe, Gent OK -->
    <div data-role="page" id="prostati2b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acute Bacterial Prostatitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a penicillin allergy but no contraindication to aminoglycosides start treatment as a single agent with:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>abp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>The total duration of therapy (intravenous + oral) is usually 4 weeks.</li>
                <li>Acute bacterial prostatitis is caused by similar organisms to those associated with other UTIs (eg <i>Escherichia coli</i>, <i>Proteus</i> species, <i>Klebsiella</i> species). However, sexually transmitted pathogens (ie <i>Chlamydia trachomatis</i>, <i>Neisseria gonorrhoeae</i>) may also cause acute bacterial prostatitis. Systemic pathogens (eg <i>Burkholderia pseudomallei</i>; see Melioidosis) rarely cause infection, except in tropical regions of Australia</li>
                <li>Acute bacterial prostatitis usually presents with symptoms associated with urinary tract infection (UTI) (eg acute dysuria, urinary frequency and urgency), and systemic features (eg fever [38Â°C or higher], chills, sweats). Obstructive urinary symptoms (eg weak stream, dribbling, hesitancy or urinary retention) and symptoms suggestive of prostatic involvement (eg pelvic or perineal pressure, or prostate tenderness on gentle digital rectal examination) may also be present.</li>
                <li>Acute bacterial prostatitis following genitourinary instrumentation (eg transrectal ultrasound-guided prostate biopsy) is often associated with sepsis and multidrug-resistant Gram-negative bacteriaâ€”seek expert advice</li>
                <li>Obtain urine samples for culture and susceptibility testing for patients with acute bacterial prostatitis. For patients in hospital, also collect blood samples for culture and susceptibility testing</li>
                <li>Prostatic abscess can complicate prostatitis. Imaging (eg transrectal ultrasound, CT scan, MRI) can identify prostatic abscesses that may require drainage</li>
                <li>Confirm the infection has resolved by repeating urine culture 1 week after treatment is completed</li>
                <li>Modify empirical therapy based on the results of culture and susceptibility testing. Do not continue empiric gentamicin for more than 48 hours</li>
                <li>See the <a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on epididymo-orchitis or acute bacterial prostatitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /prostati2b1a -->

    <!-- Start of BACTERIAL PROSTATITIS , IFD BAILOUT -->
    <div data-role="page" id="prostatix" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acute Bacterial Prostatitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid"><br>
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a contraindication to aminoglycosides or previous severe penicillin allergy:</span>
            </h3>
            <br>
            <h4 class="color-danger mrgn20b">Please contact infectious diseases for advice, treatment is complex</h4>
            <br/>
            <hr />
            <ul class="line30">
                <li>Acute bacterial prostatitis is caused by similar organisms to those associated with other UTIs (eg <i>Escherichia coli</i>, <i>Proteus</i> species, <i>Klebsiella</i> species). However, sexually transmitted pathogens (ie <i>Chlamydia trachomatis</i>, <i>Neisseria gonorrhoeae</i>) may also cause acute bacterial prostatitis. Systemic pathogens (eg <i>Burkholderia pseudomallei</i>; see Melioidosis) rarely cause infection, except in tropical regions of Australia</li>
                <li>Acute bacterial prostatitis usually presents with symptoms associated with urinary tract infection (UTI) (eg acute dysuria, urinary frequency and urgency), and systemic features (eg fever [38Â°C or higher], chills, sweats). Obstructive urinary symptoms (eg weak stream, dribbling, hesitancy or urinary retention) and symptoms suggestive of prostatic involvement (eg pelvic or perineal pressure, or prostate tenderness on gentle digital rectal examination) may also be present.</li>
                <li>Acute bacterial prostatitis following genitourinary instrumentation (eg transrectal ultrasound-guided prostate biopsy) is often associated with sepsis and multidrug-resistant Gram-negative bacteriaâ€”seek expert advice</li>
                <li>Obtain urine samples for culture and susceptibility testing for patients with acute bacterial prostatitis. For patients in hospital, also collect blood samples for culture and susceptibility testing</li>
                <li>Prostatic abscess can complicate prostatitis. Imaging (eg transrectal ultrasound, CT scan, MRI) can identify prostatic abscesses that may require drainage</li>
                <li>Confirm the infection has resolved by repeating urine culture 1 week after treatment is completed</li>
                <li>Modify empirical therapy based on the results of culture and susceptibility testing</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /prostatix -->

    <!-- END OF ACUTE BACTERIAL PROSTATITIS TREATMENT MAZE -->

    <!-- START OF EPIDIDYMO ORCHITIS TREATMENT MAZE -->

    <!-- Start of EPIDIDYMO-ORCHITIS page ?PEN -->
    <div data-role="page" id="epidi" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Epididymo-orchitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">See below for details on penicillin allergy severity</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#epidi1">No penicillin allergy</a></li>
                <li><a href="#epidi2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#epidi3">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patientâ€™s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi -->

    <!-- Start of EPIDIDYMO-ORCHITIS page NO PEN ?Severe-->
    <div data-role="page" id="epidi1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Non-sexually acquired epididymo-orchitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the infection severe or non-severe?</span>
            </h3>
            <hr />
            <ul class="line30">
                <li>Non-sexually acquired epididymo-orchitis is considered severe if the patient has fever (38Â°C or higher), systemic features (eg chills, sweats), or sepsis or septic shock</li>
                <li>If the patient is septic, please also see <a href="sepsisNsimilar.html#sepsis">treatment for sepsis</a> for further advice</li>
            </ul>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#epidi1b1">Severe and/or septic</a></li>
                <li><a href="#epidi1b2">Non-severe</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi1b -->

    <!-- Start of EPIDIDYMO-ORCHITIS page MILD PEN ?Severe-->
    <div data-role="page" id="epidi2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Non-sexually acquired epididymo-orchitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the infection severe or non-severe?</span>
            </h3>
            <hr />
            <ul class="line30">
                <li>Non-sexually acquired epididymo-orchitis is considered severe if the patient has fever (38Â°C or higher), systemic features (eg chills, sweats), or sepsis or septic shock</li>
                <li>If the patient is septic, please also see <a href="sepsisNsimilar.html#sepsis">treatment for sepsis</a> for further advice</li>
            </ul>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#epidi2b1">Severe and/or septic</a></li>
                <li><a href="#epidi2b2">Non-severe</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi2b -->

    <!-- Start of EPIDIDYMO-ORCHITIS page BAD PEN ?Severe -->
    <div data-role="page" id="epidi3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Non-sexually acquired epididymo-orchitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the infection severe or non-severe?</span>
            </h3>
            <hr />
            <ul class="line30">
                <li>Non-sexually acquired epididymo-orchitis is considered severe if the patient has fever (38Â°C or higher), systemic features (eg chills, sweats), or sepsis or septic shock</li>
                <li>If the patient is septic, please also see <a href="sepsisNsimilar.html#sepsis">treatment for sepsis</a> for further advice</li>
            </ul>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#epidi3b1">Severe and/or septic</a></li>
                <li><a href="#epidi3b2">Non-severe</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi3b -->

    <!-- Start of EPIDIDYMO-ORCHITIS page BAD PEN, Severe, ?Gent -->
    <div data-role="page" id="epidi3b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Non-sexually acquired epididymo-orchitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#epidi2b1a">Gentamicin not contraindicated</a></li>
                <li><a href="#epidix">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi3b1 -->

    <!-- Start of EPIDIDYMO-ORCHITIS page NO PEN, Severe, ?Gent -->
    <div data-role="page" id="epidi1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Non-sexually acquired epididymo-orchitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#epidi1b1a">Gentamicin not contraindicated</a></li>
                <li><a href="#epidi1b1b">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi1b1 -->

    <!-- Start of EPIDIDYMO-ORCHITIS page MILD PEN, Severe, ?Gent -->
    <div data-role="page" id="epidi2b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Non-sexually acquired epididymo-orchitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#epidi2b1a">Gentamicin not contraindicated</a></li>
                <li><a href="#epidi1b1b">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi2b1 -->

    <!-- Start of EPIDIDYMO-ORCHITIS page BAD PEN, Severe, ?Gent -->
    <div data-role="page" id="epidi3b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Non-sexually acquired epididymo-orchitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#epidi2b1a">Gentamicin not contraindicated</a></li>
                <li><a href="#epidix">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi3b1 -->

    <!-- Start of EPIDIDYMO-ORCHITIS page NO PEN, Severe, Gent OK -->
    <div data-role="page" id="epidi1b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Non-sexually acquired epididymo-orchitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient does not have a penicillin allergy and does not have a
                    contraindication to aminoglycosides give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 2 g IV, 6-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>abp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>The usual treatment duration is 14 days (intravenous + oral)</li>
                <li>Epididymo-orchitis most commonly occurs as a complication of a urethral infection caused by <i>Chlamydia trachomatis</i> or <i>Neisseria gonorrhoeae</i> in men who are sexually active, or a urinary tract infection caused by enteric Gram-negative bacteria. Men who engage in insertive anal sex are at risk of infection with sexually acquired enteric pathogens in addition to other sexually transmitted pathogens. In a significant number of cases, no pathogen is identified</li>
                <li>Please see corresponding eTG section for advice on microbiological diagnosis, if required or consult microbiology</li>
                <li>Acute scrotal pain or inflammation can be a urological emergency. Exclude alternative diagnoses (eg Fournier gangrene [see Necrotising skin and soft tissue infections], testicular torsion, testicular abscess)</li>
                <li>See the <a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on epididymo-orchitis or acute bacterial prostatitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi1b1a -->

    <!-- Start of EPIDIDYMO-ORCHITIS page NO PEN, Severe, Gent BAD -->
    <div data-role="page" id="epidi1b1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Non-sexually acquired epididymo-orchitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a contraindication to aminoglycosides:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <h4 class="color-danger mrgn20b">Gentamicin risks afre often outweighted by the benefits in severe infection or sepsis. Please contact ID for further advice</h4>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>Modify empirical therapy based on the results of culture and susceptibility testing. Please contact infectious diseases after 72 hours for advice for ongoing treatment</li>
                <li>If treating acute bacterial prostatitis, the total duration of therapy (intravenous + oral) is usually 4 weeks. If treating epididymo-orchitis the usual treatment duration is 14 days (intravenous + oral)</li>
                <li>For prepubertal boys with epididymo-orchitis suspected to be caused by an organism from the urinary tract, perform urinalysis; more than 80% of cases in these patients are not bacterial and do <b>NOT</b> require antibiotic therapy. If urinalysis is negative for leucocyte esterase and nitrite, treat the child symptomatically. If the urinalysis is positive for leucocyte esterase or nitrite, take a midstream urine sample for culture and treat as for a urinary tract infection for 14 days (see the Therapeutic Guidelines section on treatment of urinary tract infections for more details)</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on epididymo-orchitis or acute bacterial prostatitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi1b1b -->

    <!-- Start of EPIDIDYMO-ORCHITIS page NO PEN, NOT Severe -->
    <div data-role="page" id="epidi1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Non-sexually acquired epididymo-orchitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has no penicillin allergy and the infection is not severe give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for 2 weeks</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefalexin 500 mg orally, 6-hourly for 2 weeks</span>
                </h4>
            </div>
            <br/>
            <p class="mrgn20b"><b>OR,</b> if resistance to all of the above drugs is confirmed and the pathogen is susceptible, a suitable alternative is:</p>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ciprofloxacin 500 mg orally, 12-hourly for 2 weeks</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Norfloxacin 400 mg orally, 12-hourly for 2 weeks</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ciprofloxacin is:</span>
                <span class="font15 bold"> 14<script> document.write(getCode())</script>abp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOURTEEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is
                    to continue past two weeks. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Modify empirical therapy based on the results of culture and susceptibility testing. Please contact infectious diseases after 72 hours for advice for ongoing treatment</li>
                <li>For prepubertal boys with epididymo-orchitis suspected to be caused by an organism from the urinary tract, perform urinalysis; more than 80% of cases in these patients are not bacterial and do <b>NOT</b> require antibiotic therapy. If urinalysis is negative for leucocyte esterase and nitrite, treat the child symptomatically. If the urinalysis is positive for leucocyte esterase or nitrite, take a midstream urine sample for culture and treat as for a urinary tract infection for 14 days (see the Therapeutic Guidelines section on treatment of urinary tract infections for more details)</li>
                <li>Acute bacterial prostatitis usually presents with symptoms associated with urinary tract infection (UTI) (eg acute dysuria, urinary frequency and urgency), and systemic features (eg fever [38Â°C or higher], chills, sweats). Obstructive urinary symptoms (eg weak stream, dribbling, hesitancy or urinary retention) and symptoms suggestive of prostatic involvement (eg pelvic or perineal pressure, or prostate tenderness on gentle digital rectal examination) may also be present.</li>
                <li>Please see corresponding eTG section for advice on microbiological diagnosis, if required or consult microbiology</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on epididymo-orchitis or acute bacterial prostatitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi1b2 -->
    
    <!-- Start of EPIDIDYMO-ORCHITIS page NO PEN, NOT Severe -->
    <div data-role="page" id="epidi3b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Non-sexually acquired epididymo-orchitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a severe penicillin allergy and the infection is not severe give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for 2 weeks</span>
                </h4>
            </div>
            <br/>
            <p class="mrgn20b"><b>OR,</b> if resistance to all of the above drugs is confirmed and the pathogen is susceptible, a suitable alternative is:</p>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ciprofloxacin 500 mg orally, 12-hourly for 2 weeks</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Norfloxacin 400 mg orally, 12-hourly for 2 weeks</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ciprofloxacin is:</span>
                <span class="font15 bold"> 14<script> document.write(getCode())</script>abp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOURTEEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is
                    to continue past two weeks. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Modify empirical therapy based on the results of culture and susceptibility testing. Please contact infectious diseases after 72 hours for advice for ongoing treatment</li>
                <li>For prepubertal boys with epididymo-orchitis suspected to be caused by an organism from the urinary tract, perform urinalysis; more than 80% of cases in these patients are not bacterial and do <b>NOT</b> require antibiotic therapy. If urinalysis is negative for leucocyte esterase and nitrite, treat the child symptomatically. If the urinalysis is positive for leucocyte esterase or nitrite, take a midstream urine sample for culture and treat as for a urinary tract infection for 14 days (see the Therapeutic Guidelines section on treatment of urinary tract infections for more details)</li>
                <li>Acute bacterial prostatitis usually presents with symptoms associated with urinary tract infection (UTI) (eg acute dysuria, urinary frequency and urgency), and systemic features (eg fever [38Â°C or higher], chills, sweats). Obstructive urinary symptoms (eg weak stream, dribbling, hesitancy or urinary retention) and symptoms suggestive of prostatic involvement (eg pelvic or perineal pressure, or prostate tenderness on gentle digital rectal examination) may also be present.</li>
                <li>Acute bacterial prostatitis following genitourinary instrumentation (eg transrectal ultrasound-guided prostate biopsy) is often associated with sepsis and multidrug-resistant Gram-negative bacteriaâ€”seek expert advice</li>
                <li>Obtain urine samples for culture and susceptibility testing for patients with acute bacterial prostatitis. For patients in hospital, also collect blood samples for culture and susceptibility testing</li>
                <li>Prostatic abscess can complicate prostatitis. Imaging (eg transrectal ultrasound, CT scan, MRI) can identify prostatic abscesses that may require drainage</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on epididymo-orchitis or acute bacterial prostatitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi3b2 -->

    <!-- Start of EPIDIDYMO-ORCHITIS page MILD PEN, NOT Severe -->
    <div data-role="page" id="epidi2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Non-sexually acquired epididymo-orchitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has no penicillin allergy or non-severe penicillin allergy and the infection is not severe give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for 2 weeks</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefalexin 500 mg orally, 6-hourly for 2 weeks</span>
                </h4>
                </div>
                <br/>
                <p class="mrgn20b"><b>OR,</b> if resistance to all of the above drugs is confirmed and the pathogen is susceptible, a suitable alternative is:</p>
                <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ciprofloxacin 500 mg orally, 12-hourly for 2 weeks</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Norfloxacin 400 mg orally, 12-hourly for 2 weeks</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ciprofloxacin is:</span>
                <span class="font15 bold"> 14<script> document.write(getCode())</script>abp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FOURTEEN</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is
                    to continue past two weeks. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />   
            <ul class="line30">
                <li>Modify empirical therapy based on the results of culture and susceptibility testing. Please contact infectious diseases after 72 hours for advice for ongoing treatment</li>
                <li>It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use trimethoprim instead</li>
                <li>The usual treatment duration is 14 days (intravenous + oral)</li>
                <li>Epididymo-orchitis most commonly occurs as a complication of a urethral infection caused by <i>Chlamydia trachomatis</i> or <i>Neisseria gonorrhoeae</i> in men who are sexually active, or a urinary tract infection caused by enteric Gram-negative bacteria. Men who engage in insertive anal sex are at risk of infection with sexually acquired enteric pathogens in addition to other sexually transmitted pathogens. In a significant number of cases, no pathogen is identified</li>
                <li>Epididymo-orchitis can also develop after urinary tract instrumentation</li>
                <li>For prepubertal boys with epididymo-orchitis suspected to be caused by an organism from the urinary tract, perform urinalysis; more than 80% of cases in these patients are not bacterial and do <b>NOT</b> require antibiotic therapy. If urinalysis is negative for leucocyte esterase and nitrite, treat the child symptomatically. If the urinalysis is positive for leucocyte esterase or nitrite, take a midstream urine sample for culture and treat as for a urinary tract infection for 14 days (see the Therapeutic Guidelines section on treatment of urinary tract infections for more details)</li>
                <li>Obtain urine samples for culture and susceptibility testing for patients with acute bacterial prostatitis. For patients in hospital, also collect blood samples for culture and susceptibility testing</li>
                <li>Modify therapy based on the results of investigations and clinical response. If pain and swelling have not substantially reduced, oral therapy may need to be continued for up to 3 weeks</li>
                <li>Acute scrotal pain or inflammation can be a urological emergency. Exclude alternative diagnoses (eg Fournier gangrene [see Necrotising skin and soft tissue infections], testicular torsion, testicular abscess)</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on epididymo-orchitis or acute bacterial prostatitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi2b2 -->

    <!-- Start of EPIDIDYMO-ORCHITIS page MILD or BAD PEN, Severe, Gent OK -->
    <div data-role="page" id="epidi2b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Non-sexually acquired epididymo-orchitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a penicillin allergy but no contraindication to aminoglycosides start treatment as a single agent with:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>abp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Modify empirical therapy based on the results of culture and susceptibility testing. Please contact infectious diseases after 72 hours for advice for ongoing treatment</li>
                <li>The usual treatment duration is 14 days (intravenous + oral)</li>
                <li>Epididymo-orchitis most commonly occurs as a complication of a urethral infection caused by <i>Chlamydia trachomatis</i> or <i>Neisseria gonorrhoeae</i> in men who are sexually active, or a urinary tract infection caused by enteric Gram-negative bacteria. Men who engage in insertive anal sex are at risk of infection with sexually acquired enteric pathogens in addition to other sexually transmitted pathogens. In a significant number of cases, no pathogen is identified</li>
                <li>Epididymo-orchitis can also develop after urinary tract instrumentation</li>
                <li>For prepubertal boys with epididymo-orchitis suspected to be caused by an organism from the urinary tract, perform urinalysis; more than 80% of cases in these patients are not bacterial and do <b>NOT</b> require antibiotic therapy. If urinalysis is negative for leucocyte esterase and nitrite, treat the child symptomatically. If the urinalysis is positive for leucocyte esterase or nitrite, take a midstream urine sample for culture and treat as for a urinary tract infection for 14 days (see the Therapeutic Guidelines section on treatment of urinary tract infections for more details)</li>
                <li>Obtain urine samples for culture and susceptibility testing for patients with acute bacterial prostatitis. For patients in hospital, also collect blood samples for culture and susceptibility testing</li>
                <li>Modify therapy based on the results of investigations and clinical response. If pain and swelling have not substantially reduced, oral therapy may need to be continued for up to 3 weeks</li>
                <li>Acute scrotal pain or inflammation can be a urological emergency. Exclude alternative diagnoses (eg Fournier gangrene [see Necrotising skin and soft tissue infections], testicular torsion, testicular abscess)</li>
                <li>See the <a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on epididymo-orchitis or acute bacterial prostatitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi2b1a -->
    
    <!-- Start of EPIDIDYMO-ORCHITIS , IFD BAILOUT -->
    <div data-role="page" id="epidix" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Epididymo-orchitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid"><br>
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a contraindication to aminoglycosides and/or previous severe penicillin allergy:</span>
            </h3>
            <br>
            <h4 class="color-danger mrgn20b">Please contact infectious diseases for advice, treatment is complex</h4>
            <br/>
            <hr />
            <ul class="line30">
                <li>Modify empirical therapy based on the results of culture and susceptibility testing. Please contact infectious diseases after 72 hours for advice for ongoing treatment</li>
                <li>The usual treatment duration is 14 days (intravenous + oral)</li>
                <li>Epididymo-orchitis most commonly occurs as a complication of a urethral infection caused by <i>Chlamydia trachomatis</i> or <i>Neisseria gonorrhoeae</i> in men who are sexually active, or a urinary tract infection caused by enteric Gram-negative bacteria. Men who engage in insertive anal sex are at risk of infection with sexually acquired enteric pathogens in addition to other sexually transmitted pathogens. In a significant number of cases, no pathogen is identified</li>
                <li>Epididymo-orchitis can also develop after urinary tract instrumentation</li>
                <li>For prepubertal boys with epididymo-orchitis suspected to be caused by an organism from the urinary tract, perform urinalysis; more than 80% of cases in these patients are not bacterial and do <b>NOT</b> require antibiotic therapy. If urinalysis is negative for leucocyte esterase and nitrite, treat the child symptomatically. If the urinalysis is positive for leucocyte esterase or nitrite, take a midstream urine sample for culture and treat as for a urinary tract infection for 14 days (see the Therapeutic Guidelines section on treatment of urinary tract infections for more details)</li>
                <li>Obtain urine samples for culture and susceptibility testing for patients with acute bacterial prostatitis. For patients in hospital, also collect blood samples for culture and susceptibility testing</li>
                <li>Modify therapy based on the results of investigations and clinical response. If pain and swelling have not substantially reduced, oral therapy may need to be continued for up to 3 weeks</li>
                <li>Acute scrotal pain or inflammation can be a urological emergency. Exclude alternative diagnoses (eg Fournier gangrene [see Necrotising skin and soft tissue infections], testicular torsion, testicular abscess)</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidix -->

    <!-- Start of EPIDIDYMO-ORCHITIS page NO PEN ?Sexually acquired -->
    <div data-role="page" id="epidi1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Epididymo-orchitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the infection suspected to be caused by a sexually acquired pathogen or urinary tract pathogen?</span>
            </h3>
            <hr />
            <ul class="line30">
                <li>Differentiating the cause of infection (ie a sexually transmitted or urinary tract pathogen) depends on clinical judgment and patient history.</li>
                <li>If the diagnosis is uncertain, or urethral discharge is present then treat as sexually acquired</li>
                <li>If the patient is not sexually active, please treat as "Urinary tract associated pathogen"</li>
            </ul>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#epidi1a">Sexually acquired pathogen most likely</a></li>
                <li><a href="#epidi1b">Urinary tract associated pathogen (treat as acute bacterial prostatitis)</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi1 -->

    <!-- Start of EPIDIDYMO-ORCHITIS page NO PEN ?Sexually acquired -->
    <div data-role="page" id="epidi2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Epididymo-orchitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the infection suspected to be caused by a sexually acquired pathogen or urinary tract pathogen?</span>
            </h3>
            <hr />
            <ul class="line30">
                <li>Differentiating the cause of infection (ie a sexually transmitted or urinary tract pathogen) depends on clinical judgment and patient history.</li>
                <li>If the diagnosis is uncertain, or urethral discharge is present then treat as sexually acquired</li>
                <li>If the patient is not sexually active, please treat as "Urinary tract associated pathogen"</li>
            </ul>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#epidi1a">Sexually acquired pathogen most likely</a></li>
                <li><a href="#epidi2b">Urinary tract associated pathogen (treat as acute bacterial prostatitis)</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi2 -->

    <!-- Start of EPIDIDYMO-ORCHITIS page NO PEN ?Sexually acquired -->
    <div data-role="page" id="epidi3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Epididymo-orchitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the infection suspected to be caused by a sexually acquired pathogen or urinary tract pathogen?</span>
            </h3>
            <hr />
            <ul class="line30">
                <li>Differentiating the cause of infection (ie a sexually transmitted or urinary tract pathogen) depends on clinical judgment and patient history.</li>
                <li>If the diagnosis is uncertain, or urethral discharge is present then treat as sexually acquired</li>
                <li>If the patient is not sexually active, please treat as "Urinary tract associated pathogen"</li>
            </ul>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#epidix">Sexually acquired pathogen most likely</a></li>
                <li><a href="#epidi3b">Urinary tract associated pathogen (treat as acute bacterial prostatitis)</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi3 -->

    <!-- Start of EPIDIDYMO-ORCHITIS page, SEXUAL, NO/MILD PEN -->
    <div data-role="page" id="epidi1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Non-sexually acquired epididymo-orchitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has sexually acquired infection and non-severe or no penicillin allergy give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 500 mg in 2 mL of 1% lidocaine intramuscularly, or 500 mg intravenously, as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>PLUS, either</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Doxycycline 100 mg orally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> for patients likely to be nonadherent to doxycycline</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Azithromycin 1 g orally, as a single dose, repeated 1 week later</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 1<script> document.write(getCode())</script>abp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>ONE</b> dose only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is
                    to continue. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for oral azithromycin is:</span>
                <span class="font15 bold"> 7<script> document.write(getCode())</script>abp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> doses only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is
                    to continue past two doses. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Epididymo-orchitis most commonly occurs as a complication of a urethral infection caused by <i>Chlamydia trachomatis</i> or <i>Neisseria gonorrhoeae</i> in men who are sexually active, or a urinary tract infection caused by enteric Gram-negative bacteria. Men who engage in insertive anal sex are at risk of infection with sexually acquired enteric pathogens in addition to other sexually transmitted pathogens. In a significant number of cases, no pathogen is identified.</li>
                <li>Epididymo-orchitis can also occur secondary to a number of systemic bacterial infections (eg extrapulmonary tuberculosis, syphilis, brucellosis, melioidosis), viral infections (eg mumps) and non-infective conditions. Or, after urinary tract instrumentation</li>
                <li>Acute scrotal pain or inflammation can be a urological emergency. Exclude alternative diagnoses (eg Fournier gangrene [see <a href="skinNsoftTissue.html#necro">Necrotising skin and soft tissue infections</a>], testicular torsion, testicular abscess)</li>
                <li>The usual treatment duration is 14 days (intravenous + oral)</li>
                <li>Please see corresponding eTG section for advice on microbiological diagnosis, if required or consult Microbiology</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on epididymo-orchitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /epidi1a -->

    <!-- END OF EPIDIDYMO ORCHITIS TREATMENT MAZE-->

    <!-- start of pyelonephritis treatment maze -->
    <!-- Start of pyelonephritis page: #pyelo -->
    <div data-role="page" id="pyelo" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">See below for details on penicillin allergy severity</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pyelo3">No penicillin allergy</a></li>
                <li><a href="#pyelo1">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#pyelo2">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patientâ€™s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo -->

    <!-- Start of pyelonephritis Tx with Penicillin Allergy: #pyelo1 -->
    <div data-role="page" id="pyelo1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient a child? Or adult with mild or severe pyelonephritis?</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pyelo1c">Paediatric patient</a></li>
                <li><a href="#pyelo1a">Adult, mild pyelonephritis</a></li>
                <li><a href="#pyelo1b">Adult, severe pyelonephritis</a></li>
            </ul>
        </div>
        <hr />
        <ul class="line30">
            <li>Always choose severe pyelonephritis for any adult if the patient has either high grade fever or nausea
                and vomiting</li>
        </ul>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo1 -->

    <!-- Start of pyelonephritis Tx with mild Penicillin Allergy MILD: #pyelo1a -->
    <div data-role="page" id="pyelo1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Mild pyelonephritis is treated with oral antibiotics. For empirical therapy
                    while awaiting the results of cultures and susceptibility testing, use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 500 mg PO, 12-hourly for 10-14 days</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for
                    culture and susceptibility testing are taken prior to administration of antibiotics for targeted
                    therapy</li>
                <li>If there is resistance to the above agent contact infectious diseases for advice</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on pyelonephritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo1a -->

    <!-- Start of pyelonephritis Tx with mild Penicillin Allergy SEVERE: #pyelo1b -->
    <div data-role="page" id="pyelo1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pyelo1b2">Gentamicin not contraindicated</a></li>
                <li><a href="#pyelo1b1">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo1 -->

    <!-- Start of pyelonephritis Tx with Penicillin Allergy SEVERE: Gent BAD #pyelo1b1 -->
    <div data-role="page" id="pyelo1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis treatment:</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a contraindication to aminoglycosides as a single drug
                    give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 1 g IV, daily</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> if patient has septic shock or requires intensive care support give:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 1 g IV, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>pye</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>If septic, door to needle time must be within <u>ONE HOUR</u> of recognition of septic shock</li>
                <li>If septic, repeat fluid bolus every 15 minutes until patient is normotensive. </li>
                <li>If patient is not normotensive after administration of &gt; 3L of fluid, move the patient to the
                    resuscitation room ASAP if in ED, inform the supervising medical officer &#40;senior emergency
                    doctor or registrar/consultant if on a ward&#41;, refer for urgent ICU assessment. Please see the
                    severe sepsis treatment notes in the Therapeutic Guidelines for more details</li>
                <li>Wherever possible ensure that 2 x blood cultures are taken prior to administration of antibiotics to
                    allow directed therapy</li>
                <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for
                    culture and susceptibility testing are taken prior to administration of antibiotics for targeted
                    therapy</li>
                <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for
                    culture and susceptibility testing are taken prior to administration of antibiotics for targeted
                    therapy</li>
                <li>Ceftriaxone is not effective against <i>Pseudomonas aeruginosa</i>, enterococci or organisms that produce
                    extended-spectrum beta-lactamase &#40;ESBL&#41; enzymes</li>
                <li>Critically ill patients may need a higher dose of ceftriaxone &#40;2 g daily&#41; or may need to be
                    treated as per severe sepsis regimen. See <a href="sepsisNsimilar.html#sepsis">severe sepsis</a>
                </li>
                <li>Consider an early change to oral antibiotics if patient remains afebrile for 24-48 hours. Please see
                    the recommended IV duration in the Therapeutic Guidelines for details on when to make the oral
                    switch</li>
                <li>If there is resistance to ceftriaxone or the isolate is <i>Pseudomonas aeruginosa</i> contact the
                    infectious diseases registrar for advice</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on pyelonephritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo1b1 -->

    <!-- Start of pyelonephritis Tx with Penicillin Allergy SEVERE: Gent OK #pyelo1b2 -->
    <div data-role="page" id="pyelo1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient does not have a contraindication to aminoglycosides give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>pye</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for
                    culture and susceptibility testing are taken prior to administration of antibiotics for targeted
                    therapy</li>
                <li>Consider an early change to oral antibiotics if patient remains afebrile for 24-48 hours. Please see
                    the recommended IV duration in the Therapeutic Guidelines for details on when to make the oral
                    switch</li>
                <li>Use culture and susceptibility data to guide ongoing therapy within 72 hours of initiating
                    gentamicin and consider conversion to oral therapy if appropriate.</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on pyelonephritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo1b2 -->

    <!-- Start of pyelonephritis Tx with Penicillin Allergy: #pyelo2 -->
    <div data-role="page" id="pyelo2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient a child? Or adult with mild or severe pyelonephritis?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pyelo2c">Paediatric patient</a></li>
                <li><a href="#pyelo1a">Adult, mild pyelonephritis</a></li>
                <li><a href="#pyelo2b">Adult, severe pyelonephritis</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Always choose severe pyelonephritis for any adult if the patient has either high grade fever or
                    nausea and vomiting</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo2 -->

    <!-- Start of pyelonephritis Tx with mild Penicillin Allergy SEVERE: #pyelo2b -->
    <div data-role="page" id="pyelo2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15">see below for contraindications</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pyelo2b2">Gentamicin not contraindicated</a></li>
                <li><a href="#pyelo2b1">Gentamicin contraindicated</a></li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>

                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo2b -->

    <!-- Start of pyelonephritis Tx with Penicillin Anaphylaxis SEVERE: Gent BAD #pyelo2b1 -->
    <div data-role="page" id="pyelo2b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid"><br>
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a contraindication to aminoglycosides and previous
                    anaphylaxis with penicillin:</span>
            </h3>
            <br>
            <h4 class="color-danger mrgn15b">Please contact infectious diseases for advice, a decision needs to be made
                on whether to use a carbapenem in a monitored critical care environment</h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo2b1 -->

    <!-- Start of pyelonephritis Tx with Penicillin Allergy SEVERE: Gent OK #pyelo2b2 -->
    <div data-role="page" id="pyelo2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a severe penicillin allergy and does not have a
                    contraindication to aminoglycosides give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>OR</b> if patient is known or strongly suspected to be colonised with multi-drug
                    resistant Gram-negative bacteria give:</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Meropenem 1 g IV, 8-hourly</span>
                    <p class="mrgn20b">contact ID or ICU support may be required </p>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin or meropenem is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>pye</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for
                    culture and susceptibility testing are taken prior to administration of antibiotics for targeted
                    therapy</li>
                <li>Consider an early change to oral antibiotics if patient remains afebrile for 24-48 hours. Please see
                    the recommended IV duration in the Therapeutic Guidelines for details on when to make the oral
                    switch</li>
                <li>Use culture and susceptibility data to guide ongoing therapy within 72 hours of initiating
                    gentamicin and consider conversion to oral therapy if appropriate.</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on pyelonephritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo2b2 -->

    <!-- Start of pyelonephritis Tx with no Penicillin Allergy: #pyelo3 -->
    <div data-role="page" id="pyelo3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>pyelonephritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient a child? Or adult with mild or severe pyelonephritis?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pyelo3c">Paediatric patient</a></li>
                <li><a href="#pyelo3a">Adult, mild pyelonephritis</a></li>
                <li><a href="#pyelo3b">Adult, severe pyelonephritis</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Always choose severe pyelonephritis for any adult if the patient has either high grade fever or
                    nausea and vomiting</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo3 -->

    <!-- Start of pyelonephritis Tx with no Penicillin Allergy MILD: #pyelo3a -->
    <div data-role="page" id="pyelo3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Mild pyelonephritis is treated with oral antibiotics. For empirical therapy
                    while awaiting the results of cultures and susceptibility testing, use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg orally, 12-hourly for 10 to 14
                        days</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for
                    culture and susceptibility testing are taken prior to administration of antibiotics for targeted
                    therapy</li>
                <li>If there is resistance to the above agent or there is <i>Pseudomonas aeruginosa</i> contact
                    infectious diseases for advice</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on pyelonephritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo3a -->

    <!-- Start of pyelonephritis Tx with no Penicillin Allergy SEVERE: #pyelo3b -->
    <div data-role="page" id="pyelo3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pyelo3b2">Gentamicin not contraindicated</a></li>
                <li><a href="#pyelo3b1">Gentamicin contraindicated</a></li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo3b -->

    <!-- Start of pyelonephritis Tx with Penicillin Allergy SEVERE: Gent BAD #pyelo3b1 -->
    <div data-role="page" id="pyelo3b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a contraindication to aminoglycosides as a single agent
                    give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ceftriaxone 1 g IV, daily</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> if patient has septic shock or requires intensive care support give:</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ceftriaxone 1 g IV, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> if patient is known or strongly suspected to be colonised with multi-drug
                    resistant Gram-negative bacteria give:</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Meropenem 1 g IV, 8-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>pye</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for meropenem is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>pye</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>If septic, door to needle time must be within <u>ONE HOUR</u> of recognition of septic shock</li>
                <li>If septic, repeat fluid bolus every 15 minutes until patient is normotensive. </li>
                <li>If patient is not normotensive after administration of &gt; 3L of fluid, move the patient to the
                    resuscitation room ASAP if in ED, inform the supervising medical officer &#40;senior emergency
                    doctor or registrar/consultant if on a ward&#41;, refer for urgent ICU assessment. Please see the
                    severe sepsis treatment notes in the Therapeutic Guidelines for more details</li>
                <li>Wherever possible ensure that 2 x blood cultures are taken prior to administration of antibiotics to
                    allow directed therapy</li>
                <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for
                    culture and susceptibility testing are taken prior to administration of antibiotics for targeted
                    therapy</li>
                <li>Ceftriaxone is not effective against <i>Pseudomonas aeruginosa</i>, enterococci or organisms that produce
                    extended-spectrum beta-lactamase &#40;ESBL&#41; enzymes</li>
                <li>If there is resistance to ceftriaxone or the isolate is <i>Pseudomonas aeruginosa</i> contact the
                    infectious diseases registrar for advice</li>
                <li>Critically ill patients may need a higher dose of ceftriaxone &#40;2 g daily&#41; or may need to be
                    treated as per severe sepsis regimen. See <a href="sepsisNsimilar.html#sepsis">severe sepsis</a>
                </li>
                <li>Consider an early change to oral antibiotics if patient remains afebrile for 24-48 hours. Please see
                    the recommended IV duration in the Therapeutic Guidelines for details on when to make the oral
                    switch</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on pyelonephritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo3b1 -->

    <!-- Start of pyelonephritis Tx with Penicillin Allergy SEVERE: Gent OK #pyelo3b2 -->
    <div data-role="page" id="pyelo3b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient does not have a contraindication to aminoglycosides give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17"><span class="color-purple">Gentamicin given over 3-5 minutes
                            intravenously</span></span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">Septic shock or requiring intensive care support, but without
                                        known or likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Septic shock or requiring intensive care support, with known or
                                        likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Without septic shock and not requiring intensive care
                                        support:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                        </table>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 2 g IV, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> if patient is known or strongly suspected to be colonised with multi-drug
                    resistant Gram-negative bacteria replace gentamicin and Amoxicillin with:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Meropenem 1 g IV, 8-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin and meropenem is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>pye</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>If septic, door to needle time must be within <u>ONE HOUR</u> of recognition of septic shock</li>
                <li>If septic, repeat fluid bolus every 15 minutes until patient is normotensive. </li>
                <li>If patient is not normotensive after administration of &gt; 3L of fluid, move the patient to the
                    resuscitation room ASAP if in ED, inform the supervising medical officer &#40;senior emergency
                    doctor or registrar/consultant if on a ward&#41;, refer for urgent ICU assessment. Please see the
                    severe sepsis treatment notes in the Therapeutic Guidelines for more details</li>
                <li>Wherever possible ensure that 2 x blood cultures are taken prior to administration of antibiotics to
                    allow directed therapy</li>
                <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for
                    culture and susceptibility testing are taken prior to administration of antibiotics for targeted
                    therapy</li>
                <li>Ceftriaxone is not effective against <i>Pseudomonas aeruginosa</i>, enterococci or organisms that produce
                    extended-spectrum beta-lactamase &#40;ESBL&#41; enzymes</li>
                <li>If there is resistance to ceftriaxone or the isolate is <i>Pseudomonas aeruginosa</i> contact the
                    infectious diseases registrar for advice</li>
                <li>Critically ill patients may need a higher dose of ceftriaxone &#40;2 g daily&#41; or may need to be
                    treated as per severe sepsis regimen. See <a href="sepsisNsimilar.html#sepsis">severe sepsis</a>
                </li>
                <li>Consider an early change to oral antibiotics if patient remains afebrile for 24-48 hours. Please see
                    the recommended IV duration in the Therapeutic Guidelines for details on when to make the oral
                    switch</li>
                <li>Use culture and susceptibility data to guide ongoing therapy within 72 hours of initiating
                    gentamicin and consider conversion to oral therapy if appropriate.</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr>
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on pyelonephritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo3b2 -->

    <!-- Start of pyelonephritis Tx with mild Penicillin Allergy child: #pyelo1c -->
    <div data-role="page" id="pyelo1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the child younger than 1 month? Or showing signs of severe
                    illness?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pyelo1c1">&lt;1 month</a></li>
                <li><a href="#pyelo1c2">&gt;1 month with severe illness</a></li>
                <li><a href="#pyelo1c3">&gt;1 month with non-severe illness</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>If patient has any risk factors for severe illness &#40;i.e. dehydration, inability to maintain oral
                    intake, immunocompromise&#41; please choose option 1</li>
                <li>Signs of severe illness include sepsis, dehydration or inability to maintain oral intake.</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo1c -->

    <!-- Start of pyelonephritis Tx with anaphylactic Penicillin Allergy child: #pyelo2c -->
    <div data-role="page" id="pyelo2c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the child younger than 1 month? Or showing signs of severe
                    illness?</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pyelo2c1">&lt;1 month</a></li>
                <li><a href="#pyelo2c1">&gt;1 month with severe illness</a></li>
                <li><a href="#pyelo2c3">&gt;1 month with non-severe illness</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Signs of severe illness include sepsis, dehydration or inability to maintain oral intake.</li>
                <li>If patient has any risk factors for severe illness &#40;i.e. dehydration, inability to maintain oral
                    intake, immunocompromise&#41; please choose option 1</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo2c -->

    <!-- Start of pyelonephritis Tx with no Penicillin Allergy child: #pyelo3c -->
    <div data-role="page" id="pyelo3c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the child younger than 1 month? Or showing signs of severe
                    illness?</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pyelo3c1">&lt;1 month</a></li>
                <li><a href="#pyelo3c2">&gt;1 month with severe illness</a></li>
                <li><a href="#pyelo3c3">&gt;1 month with non-severe illness</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Signs of severe illness include sepsis, dehydration or inability to maintain oral intake.</li>
                <li>If patient has any risk factors for severe illness &#40;i.e. dehydration, inability to maintain oral
                    intake, immunocompromise&#41; please choose option 1</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo3c -->

    <!-- Start of pyelonephritis Tx mild Penicillin Allergy child <1month or severe: #pyelo1c1 -->
    <div data-role="page" id="pyelo1c1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pyelo1c1b">Gentamicin not contraindicated</a></li>
                <li><a href="#pyelo1c1a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo1c1 -->

    <!-- Start of pyelonephritis Tx mild Penicillin Allergy child >1month with severe: #pyelo1c1 -->
    <div data-role="page" id="pyelo1c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pyelo1c1b">Gentamicin not contraindicated</a></li>
                <li><a href="#pyelo1c2a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo1c2 -->

    <!-- Start of pyelonephritis Tx anaphylactic Penicillin Allergy child <1month or severe: #pyelo2c1 -->
    <div data-role="page" id="pyelo2c1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pyelo2c1b">Gentamicin not contraindicated</a></li>
                <li><a href="#pyelo2c1a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo2c1 -->

    <!-- Start of pyelonephritis Tx with Penicillin Allergy SEVERE: Pyelo mild #pyelo2c3 -->
    <div data-role="page" id="pyelo2c3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a contraindication to penicillin for non severe
                    pyelonephritis give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+sulfamethoxazole 4+20 mg/kg (up to 160+800 mg&#41; orally,
                        12-hourly for 7 to 10 days</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for
                    culture and susceptibility testing are taken prior to administration of antibiotics for targeted
                    therapy</li>
                <li>If there is resistance to Bactrim or the isolate is <i>Pseudomonas aeruginosa</i> contact the
                    infectious diseases registrar for advice</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on urinary tract infections in children</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo2c2 -->

    <!-- Start of pyelonephritis Tx mild Penicillin Allergy child <1month or severe: #pyelo1c1 -->
    <div data-role="page" id="pyelo3c1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pyelo3c1b">Gentamicin not contraindicated</a></li>
                <li><a href="#pyelo3c1a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo3c1 -->


    <!-- Start of pyelonephritis Tx mild Penicillin Allergy child >1month and severe: #pyelo3c2 -->
    <div data-role="page" id="pyelo3c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pyelo3c1b">Gentamicin not contraindicated</a></li>
                <li><a href="#pyelo3c2a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo3c2 -->

    <!-- Start of pyelonephritis Tx with NO Penicillin Allergy : Pyelo mild #pyelo3c2 -->
    <div data-role="page" id="pyelo3c3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pyelonephritis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a contraindication to penicillin for non severe
                    pyelonephritis give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim+sulfamethoxazole 4+20
                        mg/kg (up to 160+800 mg&#41; orally, 12-hourly for 7 to 10 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefalexin 12.5 mg/kg (up to 500
                        mg&#41; orally, 6-hourly for 7 to 10 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Amoxicillin+clavulanate 22.5+3.2
                        mg/kg up to 875+125 mg orally, 12-hourly for 7 to 10 days</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for
                    culture and susceptibility testing are taken prior to administration of antibiotics for targeted
                    therapy</li>
                <li>If there is resistance to the above agents or the isolate is <i>Pseudomonas aeruginosa</i> contact
                    the paediatric infectious diseases registrar for advice</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on urinary tract infections in children</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo3c2 -->


    <!-- Start of pyelonephritis with mild penicillin allergy child non-severe page: #pyelo1c3 -->
    <div data-role="page" id="pyelo1c3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infection with non-life threatening penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim+sulfamethoxazole
                        &#40;child 1 month or older) 4+20 mg/kg up to 160+800 mg orally, 12-hourly for 7-10 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefalexin 12.5 mg/kg up to 500 mg
                        orally, 6-hourly for 7-10 days</span>
                </h4>
            </div>
            <hr />
            <ul type="circle">
                <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and
                    susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.
                </li>
                <li>If there is resistance to the above agents or the isolate is <i>Pseudomonas aeruginosa</i> contact
                    the paediatric infectious diseases registrar for advice</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Please refer to the <a
                        href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines">CHAMP
                        guidelines</a> for further information on treating urinary tract infections in children</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on acute cystitis in children</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo1c -->



    <!-- Start of pyelonephritis Tx with Penicillin Allergy SEVERE <1month old: Gent BAD #pyelo1c1a -->
    <div data-role="page" id="pyelo1c1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe pyelonephritis treatment with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a contraindication to aminoglycosides give as a single
                    agent:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefotaxime 50 mg/kg IV, 8-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefotaxime is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>pye</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for
                    culture and susceptibility testing are taken prior to administration of antibiotics for targeted
                    therapy</li>
                <li>Ceftriaxone is not effective against <i>Pseudomonas aeruginosa</i>, enterococci or organisms that produce
                    extended-spectrum beta-lactamase &#40;ESBL&#41; enzymes</li>
                <li>Contact a paediatrician for review of all cases of pyelonephritis in children &lt; 1 month of age
                </li>
                <li>Consider an early change to oral antibiotics if patient remains afebrile for 24-48 hours. Please see
                    the recommended IV duration in the Therapeutic Guidelines for details on when to make the oral
                    switch</li>
                <li>If there is resistance to cefotaxime or the isolate is <i>Pseudomonas aeruginosa</i> contact the
                    paediatric infectious diseases registrar for advice</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on urinary tract infections in children</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo1c1a -->


    <!-- Start of pyelonephritis Tx with Penicillin Allergy SEVERE in > 1 month: Gent BAD #pyelo1c1a -->
    <div data-role="page" id="pyelo1c2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe pyelonephritis treatment with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a contraindication to aminoglycosides give as a single
                    agent:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 50 mg/kg up to 1 g IV, daily</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>pye</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for
                    culture and susceptibility testing are taken prior to administration of antibiotics for targeted
                    therapy</li>
                <li>Ceftriaxone is not effective against <i>Pseudomonas aeruginosa</i>, enterococci or organisms that produce
                    extended-spectrum beta-lactamase &#40;ESBL&#41; enzymes</li>
                <li>If there is resistance to ceftriaxone or the isolate is <i>Pseudomonas aeruginosa</i> contact the
                    paediatric infectious diseases registrar for advice</li>
                <li>Consider an early change to oral antibiotics if patient remains afebrile for 24-48 hours. Please see
                    the recommended IV duration in the Therapeutic Guidelines for details on when to make the oral
                    switch</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on urinary tract infections in children</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo1c2a -->

    <!-- Start of pyelonephritis Tx with Penicillin Allergy mild: Gent OK #pyelo1c1b -->
    <div data-role="page" id="pyelo1c1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe pyelonephritis treatment with mild penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient does not have a contraindication to aminoglycosides give as a
                    single agent:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin 7.5 mg/kg &#40;dosed based on either ideal bodyweight or
                        actual bodyweight if lower&#41; daily.</span>
                </h4>
                <p class="mrgn20b">Use culture and susceptibility data to guide ongoing therapy within 72 hours of
                    intiating gentamicin.</p>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>pye</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>If ongoing gentamicin therapy is required, AUC monitoring should be performed in collaboration with
                    pharmacy. Please contact pharmacy before the third dose for instructions</li>
                <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for
                    culture and susceptibility testing are taken prior to administration of antibiotics for targeted
                    therapy</li>
                <li>If treating a neonate gentamicin dosing must be tailored based on postmenstrual age and weight,
                    please see the <a href="dosecalcs.html#dose1">gentamicin dosing nomogram</a></li>
                <li>Contact a paediatrician for review of all cases of pyelonephritis in children &lt; 1 month of age
                </li>
                <li>Consider an early change to oral antibiotics if patient remains afebrile for 24-48 hours. Please see
                    the recommended IV duration in the Therapeutic Guidelines for details on when to make the oral
                    switch</li>
                <li>Use culture and susceptibility data to guide ongoing therapy within 72 hours of initiating
                    gentamicin and consider conversion to oral therapy if appropriate.</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on urinary tract infections in children</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo1c1b -->

    <!-- Start of pyelonephritis Tx with anaphyl Penicillin Allergy SEVERE: Gent BAD #pyelo2c1a -->
    <div data-role="page" id="pyelo2c1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe pyelonephritis treatment with severe penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a contraindication to aminoglycosides and penicillin
                    hypersensitivity:</span>

            </h3>
            <h4 class="color-danger mrgn15b">Please contact infectious diseases for advice</h4>
            <hr />
            <ul class="line30">
                <li>It is imperative that mid stream urine samples for culture and susceptibility testing are taken
                    prior to administration of antibiotics for targeted therapy</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on urinary tract infections in children</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo2c1a -->

    <!-- Start of pyelonephritis Tx with Penicillin Allergy mild: Gent OK #pyelo2c1b -->
    <div data-role="page" id="pyelo2c1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe pyelonephritis treatment with severe penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient does not have a contraindication to aminoglycosides give as a
                    single agent:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin 7.5 mg/kg &#40;dosed based on either ideal bodyweight or
                        actual bodyweight if lower&#41; IV, daily.</span>
                </h4>
                <p class="mrgn20b">Use culture and susceptibility data to guide ongoing therapy within 72 hours of
                    intiating gentamicin.</p>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>pye</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>If ongoing gentamicin therapy is required, AUC monitoring should be performed in collaboration with
                    pharmacy. Please contact pharmacy before the second dose for instructions</li>
                <li>For neonate dosing please refer to the Therapeutic Guidelines: Antibiotic</li>
                <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for
                    culture and susceptibility testing are taken prior to administration of antibiotics for targeted
                    therapy</li>
                <li>Contact a paediatrician for review of all cases of pyelonephritis in children &lt; 1 month of age
                </li>
                <li>Consider an early change to oral antibiotics if patient remains afebrile for 24-48 hours. Please see
                    the recommended IV duration in the Therapeutic Guidelines for details on when to make the oral
                    switch</li>
                <li>Use culture and susceptibility data to guide ongoing therapy within 72 hours of initiating
                    gentamicin and consider conversion to oral therapy if appropriate.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on urinary tract infections in children</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo2c1b -->

    <!-- Start of pyelonephritis Tx with no Penicillin Allergy SEVERE >1month: Gent BAD #pyelo3c2a -->
    <div data-role="page" id="pyelo3c2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe pyelonephritis treatment with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a contraindication to aminoglycosides give as a single
                    agent:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 50 mg/kg up to 1 g IV, daily</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>pye</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for
                    culture and susceptibility testing are taken prior to administration of antibiotics for targeted
                    therapy</li>
                <li>Ceftriaxone is not effective against <i>Pseudomonas aeruginosa</i>, enterococci or organisms that produce
                    extended-spectrum beta-lactamase &#40;ESBL&#41; enzymes</li>
                <li>If there is resistance to ceftriaxone or the isolate is <i>Pseudomonas aeruginosa</i> contact the
                    paediatric infectious diseases registrar for advice</li>
                <li>Consider an early change to oral antibiotics if patient remains afebrile for 24-48 hours. Please see
                    the recommended IV duration in the Therapeutic Guidelines for details on when to make the oral
                    switch</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on urinary tract infections in children</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo3c1a -->


    <!-- Start of pyelonephritis Tx with no Penicillin Allergy SEVERE <1month: Gent BAD #pyelo3c1a -->
    <div data-role="page" id="pyelo3c1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe pyelonephritis treatment with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has a contraindication to aminoglycosides give as a single
                    agent:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefotaxime 50 mg/kg IV, 8-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefotaxime is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>pye</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for
                    culture and susceptibility testing are taken prior to administration of antibiotics for targeted
                    therapy</li>
                <li>Cefotaxime is not effective against <i>Pseudomonas aeruginosa</i>, enterococci or organisms that produce
                    extended-spectrum beta-lactamase &#40;ESBL&#41; enzymes</li>
                <li>If there is resistance to cefotaxime or the isolate is <i>Pseudomonas aeruginosa</i> contact the
                    paediatric infectious diseases registrar for advice</li>
                <li>Contact a paediatrician for review of all cases of pyelonephritis in children &lt; 1 month of age
                </li>
                <li>Consider an early change to oral antibiotics if patient remains afebrile for 24-48 hours. Please see
                    the recommended IV duration in the Therapeutic Guidelines for details on when to make the oral
                    switch</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on urinary tract infections in children</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo3c1a -->

    <!-- Start of pyelonephritis Tx with no Penicillin Allergy SEVERE: Gent OK #pyelo3c1b -->
    <div data-role="page" id="pyelo3c1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe pyelonephritis treatment with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If patient does not have a contraindication to aminoglycosides give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin 7.5 mg/kg &#40;dosed based on either ideal bodyweight or
                        actual bodyweight if lower&#41; daily.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 50 mg/kg IV, 6-hourly</span>
                </h4>
                <p class="mrgn20b">Use culture and susceptibility data to guide ongoing therapy within 72 hours of
                    intiating gentamicin.</p>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>pye</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only. Starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted within 48 hours for
                    review of this patient. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>If long term gentamicin therapy is required AUC monitoring should be performed early with the first
                    dose in collaboration with pharmacy. AUC monitoring MUST be performed if more than three doses are
                    to be given</li>
                <li>This is a guide for empirical treatment only. It is imperative that mid stream urine samples for
                    culture and susceptibility testing are taken prior to administration of antibiotics for targeted
                    therapy</li>
                <li>Contact a paediatrician for review of all cases of pyelonephritis in children &lt; 1 month of age
                </li>
                <li>Consider an early change to oral antibiotics if patient remains afebrile for 24-48 hours. Please see
                    the recommended IV duration in the Therapeutic Guidelines for details on when to make the oral
                    switch</li>
                <li>Use culture and susceptibility data to guide ongoing therapy within 72 hours of initiating
                    gentamicin and consider conversion to oral therapy if appropriate.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on urinary tract infections in children</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pyelo1c1b -->
    <!-- pyelonephritis IS NOW FINISHED -->

    <!-- Urinary Tract Infections Maze Begins -->

    <!-- Start of urinary tract infection with mild penicillin allergy page: #uti1 -->
    <div data-role="page" id="utis" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infections</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have cystitis or pyelonephritis?</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cath">catheter associated cystitis</a></li>
                <li><a href="#uti">cystitis</a></li>
                <li><a href="#pyelo">pyelonephritis</a></li>
            </ul>

        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti1 -->

    <!-- Start of catheter associated UTI landing page: -->
    <div data-role="page" id="cath" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Catheter associated urinary tract infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <br/>
            <h4 class="mrgn20b generalInfo">
                <span class="font15">
                    <p>Consider the diagnosis of catheter-associated urinary tract infection (CA-UTI) in catheterised patients with signs and symptoms, including fever (38Â°C or higher), rigors, acute mental state change, flank pain, acute haematuria, or pelvic discomfort</p>
                    <h4 class="color-danger mrgn15b">Do not investigate (with urinalysis or urine culture) catheterised patients with nonspecific symptoms</h4>
                    <p>Bacteriuria, pyuria, and cloudy or malodourous urine are not reliable signs of CA-UTI in the absence of genitourinary symptoms. Inappropriate investigation (with urinalysis or urine culture) of asymptomatic patients can result in the incorrect diagnosis and treatment of CA-UTI</p>
                    <p>Urine samples for culture are often collected inappropriately as part of an evaluation of fever in patients with a catheter who do not have genitourinary symptoms. The incidence of bacteriuria associated with an indwelling urinary catheter is between 3 and 8% per day. Therefore, after a month, almost all patients with a catheter will have bacteriuria. Asymptomatic catheter-associated bacteriuria rarely results in adverse outcomes. Do not screen for or treat catheter-associated asymptomatic bacteriuria except in specific circumstancesâ€” see the Therapeutic Guidelines for Asymptomatic bacteriuria in adults</p>
                    <p>The absence of pyuria in a symptomatic catheterised patient suggests a diagnosis other than UTI</p>
                </span>
            </h4>
            <hr/>
            <h4 class="mrgn20b generalInfo">
                <span class="font15">
                    <p><b>Guide to collecting urine samples in patients with indwelling urinary catheters</b></p>
                    <br/>
                    <p><b>Remove</b> the indwelling catheter and obtain a midstream urine sample</p>
                    <p><b>OR</b> (if ongoing catheterisation is required)</p>
                    <p><b>Replace</b> the catheter [NB1], then collect a urine sample from the port in the drainage system, or if this is not possible, by separating the catheter from the drainage system</p>
                    <p>Do not collect a urine sample from the drainage bag for culture.</p>
                    <p>Ensure the pathology request clearly indicates that the urine sample provided for testing was obtained via a catheter</p>
                    <br/>
                    <p class="tinyInfo">NB1: The catheter must be replaced before collecting the urine sample to avoid culture of bacteria present in the biofilm of the catheter but not in the bladder</p>
                </span>
            </h4>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cathpen">Continue to treatment</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>See the Therapeutic Guidelines section on <a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/viewTopic?topicfile=catheter-associated-urinary-tract-infection-adults" target="_blank">catheter associated urinary tract infections in adults</a> for more information</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cath -->

    <!-- Start of urinary tract infection page: #uti -->
    <div data-role="page" id="cathpen" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Catheter associated urinary tract infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cath1">No penicillin allergy</a></li>
                <li><a href="#cath2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#cath3">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patientâ€™s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cath -->


   <!-- Start of catheter associated urinary tract infection with mild penicillin allergy page: #cath1 -->
   <div data-role="page" id="cath1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Catheter associated urinary tract infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient a child, male, female or pregnant?</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cath1a">nonpregnant woman</a></li>
                <li><a href="#cath1b">pregnant woman</a></li>
                <li><a href="#cath1c">adult male patient</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cath1 -->

    <!-- Start of catheter associated urinary tract infection with anaphylactic penicillin allergy page: #cath2 -->
    <div data-role="page" id="cath2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Catheter associated urinary tract infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient a child, male, female or pregnant?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cath2a">nonpregnant woman</a></li>
                <li><a href="#cath2b">pregnant woman</a></li>
                <li><a href="#cath2c">adult male patient</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cath2 -->

    <!-- Start of catheter associated urinary tract infection with no penicillin allergy page: #cath3 -->
    <div data-role="page" id="cath3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Catheter associated urinary tract infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient a child, male, female or pregnant?</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#cath3a">nonpregnant woman</a></li>
                <li><a href="#cath3b">pregnant woman</a></li>
                <li><a href="#cath3c">adult male patient</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cath3 -->

    <!-- Start of catheter associated urinary tract infection with mild penicillin allergy nonpregnant page: #cath1a -->
    <div data-role="page" id="cath1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Catheter associated urinary tract infection with non-life threatening penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Catheter-associated urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for
                        3 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefalexin 500 mg orally, 12-hourly
                        for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9314;</span><span class="color-purple"> Nitrofurantoin 100 mg orally,
                        12-hourly for 5 days</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. Mid stream urine samples (taken as per above) for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy</li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on catheter-associated urinary tract infection</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cath1a -->

    <!-- Start of catheter associated urinary tract infection with anaphylactic penicillin allergy nonpregnant page: #cath2a -->
    <div data-role="page" id="cath2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Catheter associated urinary tract infection with a life threatening penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Catheter-associated urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for
                        3 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Nitrofurantoin 100 mg orally,
                        12-hourly for 5 days</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. Mid stream urine samples (taken as per above) for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy</li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on catheter-associated urinary tract infection</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cath2a -->

    <!-- Start of catheter associated urinary tract infection with no penicillin allergy nonpregnant page: #cath3a -->
    <div data-role="page" id="cath3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Catheter associated urinary tract infection with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Catheter-associated urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for
                        3 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefalexin 500 mg orally, 12-hourly
                        for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9314;</span><span class="color-purple"> Nitrofurantoin 100 mg orally,
                        12-hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9315;</span><span class="color-purple"> Amoxicillin+clavulanate 500+125 mg
                        orally, 12-hourly for 5 days</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. Mid stream urine samples (taken as per above) for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy</li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on catheter-associated urinary tract infection</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cath3a -->

    <!-- Start of catheter associated urinary tract infection with mild penicillin allergy pregnant page: #cath1b -->
    <div data-role="page" id="cath1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Catheter associated urinary tract infection with a non-life threatening penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Catheter-associated urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefalexin 500 mg orally, 12-hourly
                        for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Nitrofurantoin 100 mg orally,
                        12-hourly for 5 days</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. Mid stream urine samples (taken as per above) for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy</li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on catheter-associated urinary tract infection</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cath1b -->

    <!-- Start of catheter associated urinary tract infection with anaphylactic penicillin allergy pregnant page: #cath2b -->
    <div data-role="page" id="cath2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Catheter associated urinary tract infection with a life threatening penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Catheter-associated urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Nitrofurantoin 100 mg orally, 12-hourly for 5 days</span>
                </h4>
            </div>
            <hr />
            <ul type="circle">
                <li>This is a guide for empirical treatment only. Mid stream urine samples (taken as per above) for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy</li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on catheter-associated urinary tract infection</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cath2b -->

    <!-- Start of catheter associated urinary tract infection with no penicillin allergy pregnant page: #cath3b -->
    <div data-role="page" id="cath3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Catheter associated urinary tract infection with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Catheter-associated urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefalexin 500 mg orally, 12-hourly
                        for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Nitrofurantoin 100 mg orally,
                        12-hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9314;</span><span class="color-purple"> Amoxicillin+clavulanate 500+125 mg
                        orally, 12-hourly for 5 days</span>
                </h4>
            </div>
            <hr />
            <ul type="circle">
                <li>This is a guide for empirical treatment only. Mid stream urine samples (taken as per above) for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy</li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on catheter-associated urinary tract infection</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cath3b -->

    <!-- Start of UTI with mild penicillin allergy man page: #cath1c -->
    <div data-role="page" id="cath1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult male urinary tract infection with non-life threatening penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Catheter-associated urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for
                        7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefalexin 500 mg orally, 12-hourly
                        for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9314;</span><span class="color-purple"> Nitrofurantoin 100 mg orally,
                        12-hourly for 7 days</span>
                </h4>
            </div>
            <hr />
            <ul type="circle">
                <li>All adult men presenting with a UTI require further investigation to look for prostatitis or
                    abnormality which may cause a UTI</li>
                <li>This is a guide for empirical treatment only. Mid stream urine samples (taken as per above) for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy</li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on catheter-associated urinary tract infection</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cath1c -->

    <!-- Start of UTI with anaphylactic penicillin allergy man page: #cath2c -->
    <div data-role="page" id="cath2c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult male urinary tract infection with a life threatening penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Catheter-associated urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for
                        7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Nitrofurantoin 100 mg orally,
                        12-hourly for 7 days</span>
                </h4>
            </div>
            <hr />
            <ul type="circle">
                <li>All adult men presenting with a UTI require further investigation to look for prostatitis or
                    abnormality which may cause a UTI</li>
                <li>This is a guide for empirical treatment only. Mid stream urine samples (taken as per above) for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy</li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on catheter-associated urinary tract infection</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cath2c -->

    <!-- Start of UTI with no penicillin allergy man page: #cath3c -->
    <div data-role="page" id="cath3c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult male urinary tract infection with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Catheter-associated urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefalexin 500 mg orally, 12-hourly
                        for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for
                        7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9314;</span><span class="color-purple"> Amoxicillin+clavulanate 500+125 mg
                        orally, 12-hourly for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9315;</span><span class="color-purple"> Nitrofurantoin 100 mg orally,
                        12-hourly for 7 days</span>
                </h4>
            </div>
            <hr />
            <ul type="circle">
                <li>All adult men presenting with a UTI require further investigation to look for prostatitis or
                    abnormality which may cause a UTI</li>
                <li>This is a guide for empirical treatment only. Mid stream urine samples (taken as per above) for culture and susceptibility testing should be taken prior to administration of antibiotics for targeted therapy</li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on catheter-associated urinary tract infection</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cath3c -->

    <!-- Start of urinary tract infection page: #uti -->
    <div data-role="page" id="uti" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#uti3">No penicillin allergy</a></li>
                <li><a href="#uti1">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#uti2">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patientâ€™s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti -->

    <!-- Start of urinary tract infection with mild penicillin allergy page: #uti1 -->
    <div data-role="page" id="uti1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient a child, male, female or pregnant?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#uti1a">nonpregnant woman</a></li>
                <li><a href="#uti1b">pregnant woman</a></li>
                <li><a href="#uti1c">adult male patient</a></li>
                <li><a href="#uti1d">child > 1 month old</a></li>
                <li><a href="#uti1e">child &lt; 1 month old</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti1 -->

    <!-- Start of urinary tract infection with anaphylactic penicillin allergy page: #uti2 -->
    <div data-role="page" id="uti2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient a child, male, female or pregnant?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#uti2a">nonpregnant woman</a></li>
                <li><a href="#uti2b">pregnant woman</a></li>
                <li><a href="#uti2c">adult male patient</a></li>
                <li><a href="#uti2d">child > 1 month old</a></li>
                <li><a href="#utipaed">child &lt; 1 month old</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti2 -->

    <!-- Start of urinary tract infection with no penicillin allergy page: #uti3 -->
    <div data-role="page" id="uti3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient a child, male, female or pregnant?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#uti3a">nonpregnant woman</a></li>
                <li><a href="#uti3b">pregnant woman</a></li>
                <li><a href="#uti3c">adult male patient</a></li>
                <li><a href="#uti3d">child &gt; 1 month old</a></li>
                <li><a href="#uti3e">child &lt; 1 month old</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti3 -->

    <!-- Start of urinary tract infection for any patient who is < 1 month old: #utipaed -->
    <div data-role="page" id="utipaed" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infection in a child &lt; 1 month old</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="color-danger mrgn15b">Treatment is complex, please discuss with a paediatrician</h4>
            </div>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and
                    susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.
                </li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on acute cystitis in children</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /utipaed -->

    <!-- Start of urinary tract infection with mild penicillin allergy nonpregnant page: #uti1a -->
    <div data-role="page" id="uti1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infection with non-life threatening penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for
                        3 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefalexin 500 mg orally, 12-hourly
                        for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9314;</span><span class="color-purple"> Nitrofurantoin 100 mg orally,
                        12-hourly for 5 days</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and
                    susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.
                </li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on acute cystitis in adults</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti1a -->

    <!-- Start of urinary tract infection with anaphylactic penicillin allergy nonpregnant page: #uti2a -->
    <div data-role="page" id="uti2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infection with a life threatening penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for
                        3 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Nitrofurantoin 100 mg orally,
                        12-hourly for 5 days</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and
                    susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.
                </li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on acute cystitis in adults</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti2a -->

    <!-- Start of urinary tract infection with no penicillin allergy nonpregnant page: #uti3a -->
    <div data-role="page" id="uti3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infection with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for
                        3 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefalexin 500 mg orally, 12-hourly
                        for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9314;</span><span class="color-purple"> Nitrofurantoin 100 mg orally,
                        12-hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9315;</span><span class="color-purple"> Amoxicillin+clavulanate 500+125 mg
                        orally, 12-hourly for 5 days</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and
                    susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.
                </li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on acute cystitis in adults</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti3a -->

    <!-- Start of urinary tract infection with mild penicillin allergy pregnant page: #uti1b -->
    <div data-role="page" id="uti1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infection with a non-life threatening penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefalexin 500 mg orally, 12-hourly
                        for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Nitrofurantoin 100 mg orally,
                        12-hourly for 5 days</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and
                    susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.
                </li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on acute cystitis in adults</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti1b -->

    <!-- Start of urinary tract infection with anaphylactic penicillin allergy pregnant page: #uti2b -->
    <div data-role="page" id="uti2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infection with a life threatening penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Nitrofurantoin 100 mg orally, 12-hourly for 5 days</span>
                </h4>
            </div>
            <hr />
            <ul type="circle">
                <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and
                    susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.
                </li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on acute cystitis in adults</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti2b -->

    <!-- Start of urinary tract infection with no penicillin allergy pregnant page: #uti3b -->
    <div data-role="page" id="uti3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infection with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefalexin 500 mg orally, 12-hourly
                        for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Nitrofurantoin 100 mg orally,
                        12-hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9314;</span><span class="color-purple"> Amoxicillin+clavulanate 500+125 mg
                        orally, 12-hourly for 5 days</span>
                </h4>
            </div>
            <hr />
            <ul type="circle">
                <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and
                    susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.
                </li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on acute cystitis in adults</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti3b -->

    <!-- Start of urinary tract infection with mild penicillin allergy child page: #uti1d -->
    <div data-role="page" id="uti1d" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infection with non-life threatening penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim+sulfamethoxazole
                        &#40;child 1 month or older) 4+20 mg/kg up to 160+800 mg orally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefalexin 12.5 mg/kg up to 500 mg
                        orally, 6-hourly</span>
                </h4>
            </div>
            <hr />
            <ul type="circle">
                <li>Continue treatment for 5 days in children younger than 1 year, or for 3 days in children 1 year or
                    older.</li>
                <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and
                    susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.
                </li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
                <li>Please refer to the <a
                        href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines">CHAMP
                        guidelines</a> for further information on treating urinary tract infections in children</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on acute cystitis in children</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti1d -->

    <!-- Start of urinary tract infection with anaphylactic penicillin allergy child page: #uti2d -->
    <div data-role="page" id="uti2d" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infection with a life threatening penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+sulfamethoxazole &#40;child 1 month or older&#41; 4+20 mg/kg
                        up to 160+800 mg orally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <ul type="circle">
                <li>Continue treatment for 5 days in children younger than 1 year, or for 3 days in children 1 year or
                    older.</li>
                <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and
                    susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.
                </li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
                <li>Please refer to the <a
                        href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines">CHAMP
                        guidelines</a> for further information on treating urinary tract infections in children</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on acute cystitis in children</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti2d -->

    <!-- Start of urinary tract infection with no penicillin allergy child page: #uti3d -->
    <div data-role="page" id="uti3d" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infection with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim+sulfamethoxazole
                        &#40;child 1 month or older&#41; 4+20 mg/kg up to 160+800 mg orally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefalexin 12.5 mg/kg up to 500 mg
                        orally, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9314;</span><span class="color-purple"> Amoxicillin+clavulanate 22.5+3.2
                        mg/kg up to 875+125 mg orally, 12-hourly.</span>
                </h4>
            </div>
            <hr />
            <ul type="circle">
                <li>Continue treatment for 5 days in children younger than 1 year, or for 3 days in children 1 year or
                    older.</li>
                <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and
                    susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.
                </li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>Please refer to the <a
                        href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines">CHAMP
                        guidelines</a> for further information on treating urinary tract infections in children</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on acute cystitis in children</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti3d -->


    <!--  Start of UTI page, no pen allergy age < 1 year #UTI3e> -->
    <div data-role="page" id="uti3e" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infection treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If patient has no penicillin allergy and is at risk of MRSA infection and
                is showing signs of sepsis use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomogram below</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 50 mg/kg IV, 8-hourly for 24 hours</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>uti</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Continue treatment for 5 days in children younger than 1 year, or for 3 days in children 1 year or
                    older.</li>
                <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and
                    susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.
                </li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>Please refer to the <a
                        href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines">CHAMP
                        guidelines</a> for further information on treating urinary tract infections in children</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines"
                        target="_blank">See the CHAMP guidelines</a> - See local protocol for urinary tract infections
                    in the CHAMP guidelines</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti3e -->

    <!--  Start of UTI page, MIOLDpen allergy age < 1 year #UTI1e> -->
    <div data-role="page" id="uti1e" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Urinary tract infection treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If patient has non-severe immediate or delayed penicillin hypersensitivity
                and is at risk of MRSA infection and is showing signs of sepsis use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefotaxime 50 mg/kg IV, 8-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefotaxime is: </span>
                <span class="font15 bold">5<script> document.write(getCode())</script>uti</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 5 days. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Continue treatment for 5 days in children younger than 1 year, or for 3 days in children 1 year or
                    older.</li>
                <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and
                    susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.
                </li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>Please refer to the <a
                        href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines">CHAMP
                        guidelines</a> for further information on treating urinary tract infections in children</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines"
                        target="_blank">See the CHAMP guidelines</a> - See local protocol for urinary tract infections
                    in the CHAMP guidelines</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti1e -->

    <!-- Start of UTI with mild penicillin allergy man page: #uti1c -->
    <div data-role="page" id="uti1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult male urinary tract infection with non-life threatening penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for
                        7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefalexin 500 mg orally, 12-hourly
                        for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9314;</span><span class="color-purple"> Nitrofurantoin 100 mg orally,
                        12-hourly for 7 days</span>
                </h4>
            </div>
            <hr />
            <ul type="circle">
                <li>All adult men presenting with a UTI require further investigation to look for prostatitis or
                    abnormality which may cause a UTI</li>
                <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and
                    susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.
                </li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on acute cystitis in adults</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti1c -->

    <!-- Start of UTI with anaphylactic penicillin allergy man page: #uti2c -->
    <div data-role="page" id="uti2c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult male urinary tract infection with a life threatening penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for
                        7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Nitrofurantoin 100 mg orally,
                        12-hourly for 7 days</span>
                </h4>
            </div>
            <hr />
            <ul type="circle">
                <li>All adult men presenting with a UTI require further investigation to look for prostatitis or
                    abnormality which may cause a UTI</li>
                <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and
                    susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.
                </li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on acute cystitis in adults</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti2c -->

    <!-- Start of UTI with no penicillin allergy man page: #uti3c -->
    <div data-role="page" id="uti3c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Adult male urinary tract infection with no penicillin allergy</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Urinary tract infection treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefalexin 500 mg orally, 12-hourly
                        for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Trimethoprim 300 mg orally, daily for
                        7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9314;</span><span class="color-purple"> Amoxicillin+clavulanate 500+125 mg
                        orally, 12-hourly for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9315;</span><span class="color-purple"> Nitrofurantoin 100 mg orally,
                        12-hourly for 7 days</span>
                </h4>
            </div>
            <hr />
            <ul type="circle">
                <li>All adult men presenting with a UTI require further investigation to look for prostatitis or
                    abnormality which may cause a UTI</li>
                <li>This is a guide for empirical treatment only. Mid stream urine samples for culture and
                    susceptibility testing should be taken prior to administration of antibiotics for targeted therapy.
                </li>
                <li>Take care prescribing nitrofurantoin in a patient with kidney disease, it is generally
                    contraindicated if eGFR is &lt;45mL&#47;min as it will not achieve high enough concentrations in
                    urine to treat the infection and may cause adverse effects due to high plasma concentrations</li>
                <li>If the patient has a catheter ideally this should be removed prior to treatment &#40;or at least
                    changed&#41;. If the patient is likely to require ongoing long term catheterisation it may be worth
                    discussing with infectious diseases.</li>
                <li>Asymptomatic bacteriuria usually should not be treated, except in pregnant women</li>
                <li>If there are concerns for pyelonephritis then please see the <a href="#pyelo">pyelonephritis
                        section</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on acute cystitis in adults</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /uti3c -->
    <!-- Urinary Tract Infection IS NOW FINISHED -->

</body>
<script src="bootstrap/js/script.js"></script>
<script src="bootstrap/js/test.js"></script>
<script src="bootstrap/js/email.js"></script>

</html>